FSCN1 and ovarian carcinoma: Another investigation by Kostopoulou et al. [137] analyzed the expression of FSCN1 in ovarian cancer using IHC and Western blotting and reported an upregulation of FSCN1 expression in invasive ovarian carcinomas as compared with borderline tumors and cystadenomas.